| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/26/2007 | WO2007045445A1 Dispersible tablets comprising deferasirox |
| 04/26/2007 | WO2007045352A1 Transdermal therapeutic system for administering lipophilic and/or cutaneous low-permeable active substances |
| 04/26/2007 | WO2007045151A1 Compounds and their pharmaceutical compositions for the treatment of nasal cavum hypersecretion and chronic obstructive pulmonary disease |
| 04/26/2007 | WO2007045116A1 Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof |
| 04/26/2007 | WO2007027941A3 Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| 04/26/2007 | WO2007027819A3 Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents |
| 04/26/2007 | WO2007020529A3 Method for banding hard capsules using hydroxypropylmethyl cellulose (hpmc) as a base |
| 04/26/2007 | WO2007014563A3 Anhydrous multiphase gel system |
| 04/26/2007 | WO2007011764A3 Drospirenone containing transdermal drug delivery devices and methods of delivery thereof |
| 04/26/2007 | WO2007009683A3 Pharmaceutical formulations of substituted pyrazoline compounds |
| 04/26/2007 | WO2007008752A3 Sustained release pharmaceutical compositions for highly water soluble drugs |
| 04/26/2007 | WO2007008537A3 Nanoparticulate clarithromycin formulations |
| 04/26/2007 | WO2007007189A3 Metformin methods and formulations for treating chronic constipation |
| 04/26/2007 | WO2007007014A3 Novel method for preparing chitin nanoparticles |
| 04/26/2007 | WO2007002074A3 Avian eggshell membrane polypeptide extraction via fermentation process |
| 04/26/2007 | WO2006138608A3 Pharmaceutical compositions and use thereof |
| 04/26/2007 | WO2006133048A3 Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same |
| 04/26/2007 | WO2006123364A3 Oral drug delivery system providing a coating comprising both a cellulose and a methacrylic acid derivative |
| 04/26/2007 | WO2006121560A8 Methods and compositions for treatment of cns disorders |
| 04/26/2007 | WO2006115712A3 Cellulosic films incorporating a pharmaceutically acceptable plasticizer with enhanced wettability |
| 04/26/2007 | WO2006108643A3 Organic compounds |
| 04/26/2007 | WO2006099121A3 Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof |
| 04/26/2007 | WO2006095888A3 Process for producing a mixture of particles |
| 04/26/2007 | WO2006074951A3 Orally disintegrating composition of olanzapine or donepezil |
| 04/26/2007 | WO2006066234A3 Compositions and methods for reducing lung volume |
| 04/26/2007 | WO2006060301A3 Starch derivatives and other derivatives, production processes therefor, and wound healing applications therefor |
| 04/26/2007 | WO2006040112A3 Taste-masking pharmaceutical compositions |
| 04/26/2007 | WO2006018312A9 Washing apparatus |
| 04/26/2007 | WO2006012541A8 Compositions and methods for treating excessive bleeding |
| 04/26/2007 | WO2005115356A3 Anti-microbial handle system |
| 04/26/2007 | US20070093789 Iontophoresis apparatus and method for delivery of angiogenic factors to enhance healing of injured tissue |
| 04/26/2007 | US20070093788 Iontophoresis method and apparatus for systemic delivery of active agents |
| 04/26/2007 | US20070093787 Iontophoresis device to deliver multiple active agents to biological interfaces |
| 04/26/2007 | US20070093786 Watch controller for a medical device |
| 04/26/2007 | US20070093753 Malfunction Detection Via Pressure Pulsation |
| 04/26/2007 | US20070093514 Use of 5-[4-[[3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]thiazolidine-2,4-dione or N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine; dry eyes, corneal ulcer, keratitis, conjunctivitis |
| 04/26/2007 | US20070093459 Sustained release composition for cardio-, cerebro- and peripheral vascular diseases of a Vitamin D receptor activators, e.g., paricalcitol, calcitriol, doxercalciferol, and optionally an angiotensin converting enzyme inhibitor, an angiotensin II receptor I blocker, an aldosterone blocker; no side effect |
| 04/26/2007 | US20070093445 RNA interference mediating small RNA molecules |
| 04/26/2007 | US20070093421 Bio-security system |
| 04/26/2007 | US20070093411 Diabetic inhalant formulation including surfactant and optionally preservative, isotonicizing agent, buffer and/or excipient |
| 04/26/2007 | US20070093405 Use of a solution comprising at least one nonionic surfactant |
| 04/26/2007 | US20070093403 Method for production of enzyme granules and enzyme granules produced thus |
| 04/26/2007 | US20070093161 Silicone products and methods for making silicone products |
| 04/26/2007 | US20070092583 Cold remedy composition comprising zinc salts |
| 04/26/2007 | US20070092582 Methods of preserving ophthalmic solutions and preserved ophthalmic solutions |
| 04/26/2007 | US20070092575 Compositions for administering RNAIII-inhibiting peptides |
| 04/26/2007 | US20070092574 Controlled released compositions |
| 04/26/2007 | US20070092573 Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist |
| 04/26/2007 | US20070092572 Bone cement compositions and the like comprising an RNAIII-inhibiting peptide |
| 04/26/2007 | US20070092571 Non-irritating formulation and method for the intradermal delivery of substances |
| 04/26/2007 | US20070092570 Body having an internal surface for disposing on a target tissue and a well having an opening to the internal surface; inner core with drug containing portion and an expandable material such as hydrogel in the well; delivery drugs such as eliprodil to the eye for example |
| 04/26/2007 | US20070092569 Extended release formulation of levetiracetam |
| 04/26/2007 | US20070092568 Galantamine compositions |
| 04/26/2007 | US20070092567 Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin |
| 04/26/2007 | US20070092566 Oral sustained-release tablet |
| 04/26/2007 | US20070092565 Gastric retention drug delivery system |
| 04/26/2007 | US20070092564 comprising a drug and a matrix, wherein the matrix contains an amino acid and pullulan and the ratio by weight of the amino acid to pullulan is 0.1 to 10, wherein the amino acid is selected from glycine, serine, arginine and a combination thereof; disintegrates rapidly in mouth |
| 04/26/2007 | US20070092563 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 04/26/2007 | US20070092562 Product and process for increasing compactibility of carbohydrates |
| 04/26/2007 | US20070092561 Water-Soluble Aspirin Composition |
| 04/26/2007 | US20070092560 Lipophilic Vehicle-Based Dual Controlled Release Matrix System |
| 04/26/2007 | US20070092559 Liquid dosage forms having enteric properties of delayed and then sustained release |
| 04/26/2007 | US20070092558 Methods of Preparing Targeted Immunoliposomes |
| 04/26/2007 | US20070092557 Method of preparing biodegradable dual pore polymer scaffolds for tissue engineering |
| 04/26/2007 | US20070092556 Anti-microbial material and method of making the same |
| 04/26/2007 | US20070092554 Sexual Dysfunction Compounds |
| 04/26/2007 | US20070092553 Compositions and methods of making rapidly dissolving lonically masked formulations |
| 04/26/2007 | US20070092552 Chewable lozenge cold remedy composition and method for making same |
| 04/26/2007 | US20070092543 Tablets having an emulsified polymer matrix for the controlled emission of gas, and production process |
| 04/26/2007 | US20070092540 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof |
| 04/26/2007 | US20070092539 Method of preparing an aqueous meloxicam solution and aqueous solution thus produced |
| 04/26/2007 | US20070092535 Delivery of drugs to mucosal surfaces |
| 04/26/2007 | US20070092480 Inducible release vehicles |
| 04/26/2007 | US20070092474 Carnitine salt, preliposome which contains it and dermocosmetic formula for topical use based upon said carnitine salt |
| 04/26/2007 | US20070092453 Novel Crystalline Forms of Tiotropium Bromide |
| 04/26/2007 | US20070092452 Human growth hormone (hGH); improved bioavailability |
| 04/26/2007 | US20070089739 Method and Apparatus for Nitric Oxide Generation |
| 04/26/2007 | DE4332436B4 Cyclosporin enthaltende pharmazeutische Zusammensetzungen The cyclosporin-containing pharmaceutical compositions |
| 04/26/2007 | DE10354862B4 Ramipril enthaltende feste pharmazeutische Zusammensetzungen und Verfahren zu deren Herstellung Ramipril containing solid pharmaceutical compositions and methods for their preparation |
| 04/26/2007 | DE102005051366A1 Drug Delivery Systeme Drug Delivery Systems |
| 04/26/2007 | DE102005051342A1 Verkapselung und kontrollierte Freisetzung biologisch aktiver Wirkstoffe mit enzymatisch abbaubaren hyperverzweigten Trägerpolymeren Encapsulation and controlled release of bioactive agents with enzymatically degradable hyperbranched carrier polymers |
| 04/26/2007 | CA2626704A1 Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof |
| 04/26/2007 | CA2626613A1 Ramipril formulation with increased stability |
| 04/26/2007 | CA2626357A1 Intranasal administration of rapid acting insulin |
| 04/26/2007 | CA2626242A1 Polymorph transformation of zolpidem in tablet matrix |
| 04/26/2007 | CA2625875A1 Encapsulation system |
| 04/26/2007 | CA2625776A1 Pharmaceutical packaging of an oral dosage combination |
| 04/26/2007 | CA2625581A1 Therapy patch |
| 04/26/2007 | CA2625143A1 Dental and endodontic filling materials and methods |
| 04/26/2007 | CA2625112A1 Dispersible tablets comprising deferasirox |
| 04/26/2007 | CA2624906A1 Thermoset particles and methods for production thereof |
| 04/26/2007 | CA2624897A1 Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency |
| 04/26/2007 | CA2624837A1 Method for treating primary and secondary forms of glaucoma |
| 04/26/2007 | CA2602577A1 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues |
| 04/26/2007 | CA2557369A1 Liquid, peg-free, cold-processable oil-in-water emulsifiers obtainable by combining emulsifiers based on polyol partial esters and acid partial esters |
| 04/25/2007 | EP1777231A2 Process of purication of LH and recominant hLH purified by that method |
| 04/25/2007 | EP1776953A1 Solid oral dosage forms comprising valsartan |
| 04/25/2007 | EP1776950A1 Opioid formulations for treating pain |
| 04/25/2007 | EP1776949A2 A porous, molecularly imprinted polymer and a process for the preparation thereof |
| 04/25/2007 | EP1776948A1 Method of producing liposome-containing preparation |